Triple

T22456951
Position Surface form Disambiguated ID Type / Status
Subject ICH Q1 Stability Testing of New Drug Substances and Products E555140 entity
Predicate hasPart P35 FINISHED
Object ICH Q1C — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH Q1C | Statement: [ICH Q1 Stability Testing of New Drug Substances and Products, hasPart, ICH Q1C]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: ICH Q1C
Context triple: [ICH Q1 Stability Testing of New Drug Substances and Products, hasPart, ICH Q1C]
  • A. ICH Q1
    ICH Q1 is an international guideline that sets standards for the stability testing of new drug substances and products to ensure their quality, safety, and efficacy over time.
  • B. ICH Q1B
    ICH Q1B is an International Council for Harmonisation guideline that provides standards for photostability testing of new drug substances and drug products.
  • C. CIQ
    CIQ is a technology company that provides enterprise support and services for Rocky Linux and other open-source infrastructure solutions.
  • D. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • E. CA-QC
    CA-QC is the ISO 3166-2 subdivision code that uniquely identifies the Canadian province of Quebec.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: ICH Q1C
Target entity description: ICH Q1C is an International Council for Harmonisation guideline that provides specific recommendations on stability testing requirements for new drug substances and products intended for climatic zones III and IV.
  • A. ICH Q1
    ICH Q1 is an international guideline that sets standards for the stability testing of new drug substances and products to ensure their quality, safety, and efficacy over time.
  • B. ICH Q1B
    ICH Q1B is an International Council for Harmonisation guideline that provides standards for photostability testing of new drug substances and drug products.
  • C. CIQ
    CIQ is a technology company that provides enterprise support and services for Rocky Linux and other open-source infrastructure solutions.
  • D. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • E. CA-QC
    CA-QC is the ISO 3166-2 subdivision code that uniquely identifies the Canadian province of Quebec.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7c428c8190847a259eef969525 completed April 29, 2026, 1:14 a.m.
Created at: April 16, 2026, 8:48 p.m.